✦ LIBER ✦

257 Design of RESILIENCE: a Phase 3 TRial Comparing CapecitabinE in Combination with SorafenIb or PLacebo for Treatment of Locally Advanced or MetastatIc HER2-Negative Breast CancEr

✍ Scribed by J. Baselga; F. Costa; H. Gomez; C. Hudis; B. Rapoport; H. Roche; L.S. Schwartzberg; O. Petrenciuc; M. Shan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety results from a phase III study (T

✍ I. Lang; M.J. Inbar; Z. Kahán; R. Greil; S. Beslija; S.M. Stemmer; B. Kaufman; Z 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 302 KB

Motesanib, or open-label bevacizumab, in

✍ Miguel Martin; Henri Roche; Tamas Pinter; John Crown; M John Kennedy; Louise Pro 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 230 KB

Phase II trial of a novel capecitabine d

✍ Devika Gajria; Joseph Gonzalez; Kimberly Feigin; Sujata Patil; Carol Chen; Maria 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 219 KB

Phase II Interventional Study (N0337) of

✍ Winston W. Tan; Jacob B. Allred; Muhammad Salim; Patrick Flynn; Paul A.S. Fishki 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 354 KB

Survival update of so14999 a large phase

✍ R. Leonard; G. Cervantes; W. Lui; L. Mauriac; D. Miles; V. Moiseyenko; C. Chan N 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 190 KB

A phase I/II trial of non-pegylated lipo

✍ D. Amadori; C. Milandri; G. Comella; S. Saracchini; S. Salvagni; C. Barone; R. B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 226 KB